These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15359881)

  • 41. [Treatment of chronic hepatitis C and alcohol consumption].
    Mathurin P; Canva V; Dharancy S; Paris JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B248-51. PubMed ID: 12180297
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment strategies for viral hepatitis].
    Matsushima T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):133-5. PubMed ID: 11968844
    [No Abstract]   [Full Text] [Related]  

  • 43. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders.
    Glaser D
    Am J Gastroenterol; 2000 Nov; 95(11):3315-6. PubMed ID: 11095370
    [No Abstract]   [Full Text] [Related]  

  • 44. [Autoimmune hepatitis: progress in its treatment].
    Nakamura K; Makino I
    Nihon Naika Gakkai Zasshi; 1999 Apr; 88(4):591-6. PubMed ID: 10341642
    [No Abstract]   [Full Text] [Related]  

  • 45. Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy.
    Sezaki H; Arase Y; Tsubota A; Suzuki Y; Kobayashi M; Saitoh S; Suzuki F; Akuta N; Someya T; Ikeda K; Kumada H
    J Gastroenterol; 2003; 38(5):493-500. PubMed ID: 12768394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
    Alavian SM; Tabatabaei SV
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):123-4. PubMed ID: 19959942
    [No Abstract]   [Full Text] [Related]  

  • 47. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
    Mauss S
    J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].
    Yoshida H; Tateishi R; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):511-4. PubMed ID: 15359852
    [No Abstract]   [Full Text] [Related]  

  • 49. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 50. Consensus conference. Treatment of hepatitis C.
    Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES)
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B303-20. PubMed ID: 12180305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Weight loss in HIV-infected patients.
    Garcia-Benayas T; Blanco F; Soriano V
    N Engl J Med; 2002 Oct; 347(16):1287-8. PubMed ID: 12393835
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluating the evidence from clinical trials in chronic hepatitis C.
    Brown RS
    J Viral Hepat; 2006 May; 13 Suppl 1():15-25. PubMed ID: 16630043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interferon treatment in chronic HCV hepatitis and autoimmune hypothyroidism].
    Calvo Manuel E; Nieto Sánchez A; Espinos Pérez D
    An Med Interna; 2000 Mar; 17(3):164-5. PubMed ID: 10804649
    [No Abstract]   [Full Text] [Related]  

  • 54. Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection.
    Matsumoto K; Kikuchi K; Kajiyama Y; Takano Y; Mabuchi M; Doi S; Sato K; Miyakawa H; Yasuda I
    Intern Med; 2018 Sep; 57(18):2669-2673. PubMed ID: 29709942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late autoimmune hepatitis after hepatitis C therapy.
    Efe C; Heurgué-Berlot A; Ozaslan E; Purnak T; Thiéfin G; Simsek H; Wahlin S
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1308-11. PubMed ID: 23628974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Splenectomy before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia].
    Aizawa N; Nishiguchi S
    Nihon Rinsho; 2011 May; 69 Suppl 4():201-5. PubMed ID: 22096919
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals.
    Fleischer-Stępniewska K; Rymer W; S M; Zalewska M; Knysz B; Inglot M
    Pol Arch Intern Med; 2019 Mar; 129(3):215-218. PubMed ID: 30758316
    [No Abstract]   [Full Text] [Related]  

  • 58. Bipolar disorder and interferon treatment: how to manage?
    Aalouane R; Hafidi H; Rammouz I
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):1002. PubMed ID: 23817449
    [No Abstract]   [Full Text] [Related]  

  • 59. Autoimmune gastritis and HCV chronic hepatitis: a possible association in presence of mild iron deficiency anemia.
    Casella G; Villanacci V; Perego D; Somma A; Monti C; Baldini V
    J Clin Gastroenterol; 2004 Oct; 38(9):832. PubMed ID: 15365420
    [No Abstract]   [Full Text] [Related]  

  • 60. Manic episode associated with citalopram therapy for interferon-induced depression in a patient with chronic hepatitis C infection.
    Wu PL; Liao KF; Peng CY; Pariante CM; Su KP
    Gen Hosp Psychiatry; 2007; 29(4):374-6. PubMed ID: 17591516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.